← Back to Analyst Consensus 
PACB Buy
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Current Price —
Implied Upside —
Analysts 14
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 11, 2026 | Barclays | maintain | Underweight → Underweight | — | 53% |
| Apr 14, 2026 | Barclays | maintain | Underweight → Underweight | — | 53% |
| Mar 6, 2026 | Barclays | downgrade | Equal-Weight → Underweight | — | 53% |
| Dec 15, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $2 | 53% |
| Nov 11, 2025 | Piper Sandler | maintain | Neutral → Neutral | $2 | 54% |
| Nov 10, 2025 | Stephens & Co. | maintain | Overweight → Overweight | $2 | 54% |
| Aug 11, 2025 | Piper Sandler | maintain | Neutral → Neutral | $1.5 | 54% |
| Jun 25, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $1.5 | 53% |
| May 15, 2025 | Piper Sandler | maintain | Neutral → Neutral | $1.25 | 54% |
| May 15, 2025 | Stephens & Co. | reiterate | Overweight → Overweight | $1.8 | 54% |
| Apr 10, 2025 | Canaccord Genuity | maintain | Buy → Buy | $3 | 48% |
| Mar 25, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $2 | 55% |
| Feb 20, 2025 | Piper Sandler | reiterate | Neutral → Neutral | $2 | 54% |
| Feb 18, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $1.5 | 54% |
| Feb 18, 2025 | Stephens & Co. | reiterate | Overweight → Overweight | $2.5 | 54% |
| Feb 14, 2025 | Stephens & Co. | reiterate | Overweight → Overweight | $2.5 | 54% |
| Jan 23, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $1.75 | 54% |
| Nov 11, 2024 | UBS | downgrade | Buy → Neutral | $2 | 54% |
| Nov 11, 2024 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $6 | 55% |
| Nov 11, 2024 | Piper Sandler | maintain | Neutral → Neutral | $2.5 | 54% |
| Aug 28, 2024 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $7 | 55% |
| Aug 13, 2024 | Stephens & Co. | maintain | Overweight → Overweight | $2.5 | 54% |
| Aug 12, 2024 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $2 | 54% |
| Aug 8, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $3.5 | 50% |
| Aug 8, 2024 | Canaccord Genuity | maintain | Buy → Buy | $3 | 48% |
| Jun 3, 2024 | Jefferies | initiate | — → Buy | $4 | 52% |
| May 15, 2024 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $4 | 54% |
| May 13, 2024 | Piper Sandler | maintain | Neutral → Neutral | $2 | 54% |
| May 10, 2024 | Barclays | maintain | Equal-Weight → Equal-Weight | $2 | 53% |
| Apr 22, 2024 | JP Morgan | downgrade | Overweight → Neutral | $0 | 55% |
| Apr 19, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $2.5 | 54% |
| Apr 18, 2024 | Bernstein | maintain | Outperform → Outperform | $2.5 | 52% |
| Apr 18, 2024 | Goldman Sachs | downgrade | Buy → Neutral | $2.5 | 54% |
| Apr 18, 2024 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $8 | 55% |
| Apr 17, 2024 | TD Cowen | maintain | Buy → Buy | $2.5 | 54% |
| Apr 10, 2024 | Barclays | maintain | Equal-Weight → Equal-Weight | $3 | 53% |
| Apr 10, 2024 | Goldman Sachs | maintain | Buy → Buy | $7 | 54% |
| Mar 22, 2024 | Canaccord Genuity | maintain | Buy → Buy | $10 | 48% |
| Feb 16, 2024 | UBS | maintain | Buy → Buy | $12 | 54% |
| Dec 14, 2023 | Guggenheim | initiate | — → Neutral | $0 | 52% |
| Dec 14, 2023 | Stephens & Co. | initiate | — → Overweight | $11 | 54% |
| Dec 13, 2023 | Wolfe Research | initiate | — → Peer Perform | $0 | 53% |
| Nov 17, 2023 | UBS | upgrade | Neutral → Buy | $10 | 54% |
| Nov 6, 2023 | Piper Sandler | maintain | Neutral → Neutral | $8 | 54% |
| Oct 31, 2023 | Canaccord Genuity | maintain | Buy → Buy | $15 | 48% |
| Oct 31, 2023 | Cantor Fitzgerald | upgrade | Neutral → Overweight | $11 | 50% |
| Oct 24, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $10 | 54% |
| Oct 16, 2023 | Piper Sandler | maintain | Neutral → Neutral | $9 | 54% |
| Sep 29, 2023 | Barclays | maintain | Equal-Weight → Equal-Weight | $9 | 53% |
| Sep 28, 2023 | Bernstein | initiate | — → Outperform | $11 | 52% |
Price Target Trend
Apr 26, 2026 Oct 26, 2026
EPS Estimates
0y —
+1q —
+1y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days